1 Cannabis Stock to Buy and 1 to Dump After Yesterday’s Performance

These two cannabis stocks had drastically different reactions in the market yesterday. Both were based on market news that investors have been watching for months.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks continue to drop like stones across the board. Well, almost all cannabis stocks. Yesterday saw the drop continue for Hexo (TSX:HEXO)(NASDAQ:HEXO). Another cannabis company saw shares climb higher and higher.

Hexo plunges 10%

Hexo cannabis stock released its earnings report, and investors were disappointed to see its shares plunge to below $1 per share before climbing just above the dollar mark. The company reported a loss of $116.9 million in its first quarter, amounting to a loss of $0.46 per diluted share. That’s compared to a loss of $4.2 million and $0.04 per diluted share the year before.

This led to the company announcing a shakeup in leadership and its strategic plan. The new plan will be to streamline its business, reduce costs, and improve growth. Further, the company “overhauled” its operations and leadership. Co-founder and chief executive Sebastian St-Louis along with chief operating officer Donald Courtney left back in October. Now, Scott Cooper, the new CEO, unveiled a plan to reduce costs and restructure the organization.

Still, it’s more bad news for Hexo stock that investors weren’t fans of. And until Cooper can prove his plan actually works, Hexo remains a volatile stock. If it’s on your buy list, you may want to dump it for now until there’s some marked improvement from this company.

Shares of Hexo stock trade at $1.11 as of writing, down 82% year to date.

Nova Cannabis jumps 17%

It wasn’t all bad news for cannabis stocks. In fact, Nova Cannabis (TSX:NOVC) received some positive news that sent its share up 17%. This came after Alcanna, one of the largest private sector alcohol retailers in North America and largest in Canada, agreed that Sundial Growers would acquire Alcanna. In the deal, Alcanna shareholders would receive 10.69 shares of Sundial for each Alcanna share.

Alcanna is a majority owner of Nova Cannabis, and it now has a cannabis-focused parent company. This could be enormous for the growth of the company, which already has 70 cannabis retail stores in Alberta, Ontario, and Saskatchewan. And frankly, it’s something Sundial needs after its less-than-ideal performance last quarter.

Yet it’s one of the first moves for Sundial to prove it’s on the path to growth, perhaps through these acquisitions in the cannabis sector. While it remains a popular meme stock, Nova Cannabis could be a solid benefactor from Sundial growth, with less volatility.

Nova Cannabis currently has a target price of $5.50, representing a potential upside of 64%. Shares are up 2% year to date after a few corrections this year.

Word of warning

With either of these cannabis stocks, there is still a lot of volatility in the cannabis sector. Both could see drops as investors wax and wane over whether there will be another jump in the future. This situation could be entirely reversed in a month. Who knows? So, make sure to continue being vigilant if you’re going to get into cannabis stocks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns HEXO Corp. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »